Showing 4321-4340 of 8668 for: Cochrane Systematic Reviews Back
- Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Cochrane Systematic Reviews, 30-Oct-2013
Intrauterine insemination (IUI) is a common treatment for couples with subfertility that does not involve the fallopian tubes. It is used to bring the sperm close to the released oocyte. Another method of introducing sperm is fallopian tube sperm perfusio
- Intrauterine insemination versus intracervical insemination in donor sperm treatment
Cochrane Systematic Reviews, 25-Jan-2018
The first-line treatment in donor sperm treatment consists of inseminations that can be done by intrauterine insemination (IUI) or by intracervical insemination (ICI).
- Intra‐uterine insemination versus timed intercourse or expectant management for cervical hostility in subfertile couples
Cochrane Systematic Reviews, 19-Oct-2005
The postcoital test has poor diagnostic and prognostic characteristics. Nevertheless, some physicians believe it can identify scanty or abnormal mucus that might impair fertility. One way to avoid 'hostile' cervical mucus is intrauterine insemination. Wit
- Intravascular brachytherapy for peripheral vascular disease
Cochrane Systematic Reviews, 8-Jan-2014
Interventional treatment of arteries that are narrowed and obstructed by atherosclerosis involves either bypassing the blockage using a graft; widening the artery from the inside with a balloon, a procedure known as percutaneous transluminal angioplasty (
- Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
Cochrane Systematic Reviews, 20-Sep-2016
Alpha-1 antitrypsin deficiency is an inherited disorder that can cause chronic obstructive pulmonary disease (COPD). People who smoke are more seriously affected and have a greater risk of dying from the disease. Therefore, the primary treatment is to hel
- Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
Cochrane Systematic Reviews, 20-Apr-2005
Since the advent of inhaled ß2 -agonists, anticholinergic agents and glucocorticoids, the role of aminophylline in paediatric acute asthma has become less clear. There remains some consensus that it is beneficial in children with acute severe asthma, rece
- Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
Cochrane Systematic Reviews, 29-Jun-2017
Cystic fibrosis is a multi-system disease characterised by the production of thick secretions causing recurrent pulmonary infection, often with unusual bacteria. Intravenous antibiotics are commonly used in the treatment of acute deteriorations in symptom
- Intravenous beta2‐agonists for acute asthma in the emergency department
Cochrane Systematic Reviews, 22-Jan-2001
Inhaled beta-agonist therapy is central to the management of acute asthma. The use of intravenous beta-agonist agents may also be beneficial in this setting.
- Intravenous beta2-agonists versus intravenous aminophylline for acute asthma
Cochrane Systematic Reviews, 13-Nov-2012
Inhaled beta2-agonist therapy is central to the management of acute asthma. For rapid bronchodilation in severe cases, penetration of inhaled drug to the affected small conducting airway may be impeded, and the intravenous (IV) rather than inhaled adminis
- Intravenous dexamethasone for extubation of newborn infants
Cochrane Systematic Reviews, 23-Oct-2001
Endotracheal tubes are foreign bodies that may injure the upper airway causing laryngeal edema. This in turn may result in failure of extubation in preterm infants. Corticosteroids have been used prophylactically to reduce upper airway obstruction and fac
- Intravenous fluids for abdominal aortic surgery
Cochrane Systematic Reviews, 20-Jan-2010
Surgery on the abdominal aorta to treat aneurysms or occlusive disease is a major undertaking which requires intensive physiological support and fluid management. Blood products are often used but the main fluid replacement is with crystalloids or colloid
- Intravenous fluids for reducing the duration of labour in low risk nulliparous women
Cochrane Systematic Reviews, 18-Jun-2013
Several factors may influence the progression of normal labour. It has been postulated that the routine administration of intravenous fluids to keep women adequately hydrated during labour may reduce the period of contraction and relaxation of the uterine
- Intravenous heparin during ruptured abdominal aortic aneurysmal repair
Cochrane Systematic Reviews, 19-Aug-2016
There have been enormous advances in the screening, diagnosis, intervention and overall prognosis of abdominal aortic aneurysms (AAAs) in the last decade, but despite these, ruptured AAAs (rAAAs) still cause around 3500 to 6000 deaths in England and Wales
- Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Cochrane Systematic Reviews, 31-Jan-2013
Wegener's granulomatosis (WG) is a necrotizing small-vessel vasculitis that can affect any organ in the body but mainly affects the upper and lower respiratory tract, the kidneys, joints, skin and eyes. The current mainstay of remission induction therapy
- Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 20-Dec-2013
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, developing over at least two months. Uncontrolled studies suggest that intravenous immunoglobulin (IVIg) helps. This revie
- Intravenous immunoglobulin for Guillain‐Barré syndrome
Cochrane Systematic Reviews, 19-Sep-2014
Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in 2001 and previously updated in 200
- Intravenous immunoglobulin for myasthenia gravis
Cochrane Systematic Reviews, 12-Dec-2012
Myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission. As with other autoimmune diseases, people with myasthenia gravis would be expected to benefit from intravenous immunoglobulin (IVIg). This is an
- Intravenous immunoglobulin for presumed viral myocarditis in children and adults
Cochrane Systematic Reviews, 19-Aug-2020
This is an update of a previous review. Case reports and case series have described dramatic responses to intravenous immunoglobulin (IVIG) in people with presumed viral myocarditis, and its administration has become commonplace.
- Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants
Cochrane Systematic Reviews, 29-Jan-2020
Nosocomial infections continue to be a significant cause of morbidity and mortality among preterm and/or low birth weight (LBW) infants. Preterm infants are deficient in immunoglobulin G (IgG); therefore, administration of intravenous immunoglobulin (IVIG
- Intravenous immunoglobulin for suspected or proven infection in neonates
Cochrane Systematic Reviews, 29-Jan-2020
Neonates are at higher risk of infection due to immuno-incompetence. Maternal transport of immunoglobulins to the fetus mainly occurs after 32 weeks' gestation, and endogenous synthesis begins several months after birth. Administration of intravenous immu
